Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection.
about
Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infectionsDaptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococciPhage therapy against Enterococcus faecalis in dental root canalsInfluence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?A single-center experience with infections due to daptomycin-nonsusceptible Enterococcus faecium in liver transplant recipients.A potential role for daptomycin in enterococcal infections: what is the evidence?Defining daptomycin resistance prevention exposures in vancomycin-resistant Enterococcus faecium and E. faecalis.Whole-genome analyses of Enterococcus faecium isolates with diverse daptomycin MICs.Identification of a novel clone, ST736, among Enterococcus faecium clinical isolates and its association with daptomycin nonsusceptibility.Daptomycin resistance in enterococci is associated with distinct alterations of cell membrane phospholipid contentA review of daptomycin for injection (Cubicin) in the treatment of complicated skin and skin structure infections.A liaR deletion restores susceptibility to daptomycin and antimicrobial peptides in multidrug-resistant Enterococcus faecalis.Genetic basis for in vivo daptomycin resistance in enterococci.Multiple roles for Enterococcus faecalis glycosyltransferases in biofilm-associated antibiotic resistance, cell envelope integrity, and conjugative transfer.[Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci.Comparative Analysis of the Orphan CRISPR2 Locus in 242 Enterococcus faecalis Strains.The ribosomal S10 protein is a general target for decreased tigecycline susceptibilityCorrelation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpoints.Deletion of liaR Reverses Daptomycin Resistance in Enterococcus faecium Independent of the Genetic BackgroundRampant Parasexuality Evolves in a Hospital Pathogen during Antibiotic Selection.Oritavancin--an investigational glycopeptide antibiotic.Mechanisms of resistance to daptomycin in Enterococcus faecium.Whole-genome analysis of a daptomycin-susceptible enterococcus faecium strain and its daptomycin-resistant variant arising during therapyBiochemical characterization of cardiolipin synthase mutations associated with daptomycin resistance in enterococci.Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections.Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureus.Genetic modifications to temperate Enterococcus faecalis phage Ef11 that abolish the establishment of lysogeny and sensitivity to repressor, and increase host range and productivity of lytic infection.A liaF codon deletion abolishes daptomycin bactericidal activity against vancomycin-resistant Enterococcus faecalis.Daptomycin-resistant Enterococcus faecalis diverts the antibiotic molecule from the division septum and remodels cell membrane phospholipids.Exogenous Fatty Acids Protect Enterococcus faecalis from Daptomycin-Induced Membrane Stress Independently of the Response Regulator LiaR.Prescribing trends with daptomycin (cubicin) for the treatment of gram-positive infectionsA current perspective on daptomycin for the clinical microbiologist.Adaptation of Enterococcus faecalis to daptomycin reveals an ordered progression to resistancePre-clinical experience with daptomycin.Fosfomycin Enhances the Activity of Daptomycin against Vancomycin-Resistant Enterococci in an In Vitro Pharmacokinetic-Pharmacodynamic Model.Emergence and management of drug-resistant enterococcal infections.Resistant pathogen-associated skin and skin-structure infections: antibiotic options.Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model.Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates.
P2860
Q26752922-8127B855-337D-4E7D-9233-318AA393B156Q26851754-A9DAFB18-C48B-4A13-AB4A-C1F5AFC48BE1Q28071930-67A92E84-B119-4C14-9C6C-6CC9B7CAEFA8Q30277034-FF74DE60-A888-4C58-BE3F-E2073D77B88DQ30277188-4C2BA35B-9768-443D-A09C-1FACDFF7E963Q33845776-92275589-D2DE-4F58-9942-7CF4AD5A9D0AQ34057475-DAD0AF29-30F2-4A1E-ADF1-059D91A6F956Q34058150-AAD79681-9EEA-4886-B469-6E3B99EE954BQ34058360-E7422822-1253-401F-A4C3-4152CFDAFBDDQ34405922-3EE082D7-89D1-46F1-8C46-32613B8FC46AQ35166807-3D3D2C03-E3E3-433D-9908-2F4BA6C66711Q35473516-26A41378-33CD-4528-A4B3-C50842619DC3Q35499202-CDB584AA-9FEA-4AE5-8D05-D4ADA11002FCQ35616215-A7DA2CF9-A64F-478A-9517-24136ED9A29BQ35619094-0F4A9699-6684-489D-BEF0-71055D380FC2Q35746209-74F272C9-804A-44FD-8F0C-F279C23CF94FQ35784992-402E68FF-DF23-4BAE-9214-C35C75709A3FQ35960763-74E411F5-6489-45B9-BEF5-6002BEF4F311Q36171704-5C43406E-7A14-4F81-8AFC-320A1C2B5D24Q36290600-3187BBBD-CD14-443C-AD9C-480AC728DC33Q36382284-1461E48C-73B2-44A1-BF6B-AB5B4F4A81C6Q36426011-D1793811-76A8-4E7B-9854-A9B515071A46Q36482920-8936D706-C386-4531-A726-D76BAD51CA1BQ36505376-C3007C6A-809F-46CC-A72C-BE0CFD64956EQ36505466-2D13E453-BC3C-4623-B554-6429603BCB5CQ36777821-2EA489CA-B472-45C3-9A52-93E25A3BC7BFQ36903680-A7C5A8B8-0326-494B-BA26-F08284CAD058Q37007036-26663100-45A5-4570-8F5B-1C76B5869AABQ37026557-10752D13-626E-4782-B673-6A5C759C4E65Q37074688-81E1740C-CE35-4DEE-BB75-8FFB1BC3949FQ37122276-C147B70D-53AF-42AD-9DD4-E733C8EBFD77Q37195896-AFDDA4F0-6118-4375-AE0D-A0E8602B77D9Q37263289-A1492E81-093C-4676-BE38-45307446F725Q37263496-5FCBFE1A-6A06-4985-8F9F-243D03055770Q37284356-E80E0B6F-62D4-4875-884F-220349FF675BQ37287661-4637B494-ED79-41FC-9A0C-B50CE9E3535DQ37291346-A1855C1C-1B63-45AB-BA87-A514B5F42B44Q37785546-DB3D6686-B4EE-420B-8F10-1C2861AB8FD1Q38325979-09335A77-FA0D-4301-9F58-96397ECFEC0DQ38474869-75CF2FA3-AC1E-4DAD-A25E-64795ECD4512
P2860
Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Emergence of resistance to dap ...... terococcus faecalis infection.
@en
Emergence of resistance to dap ...... terococcus faecalis infection.
@nl
type
label
Emergence of resistance to dap ...... terococcus faecalis infection.
@en
Emergence of resistance to dap ...... terococcus faecalis infection.
@nl
prefLabel
Emergence of resistance to dap ...... terococcus faecalis infection.
@en
Emergence of resistance to dap ...... terococcus faecalis infection.
@nl
P2093
P356
P1476
Emergence of resistance to dap ...... terococcus faecalis infection.
@en
P2093
John P Quinn
Karen Lolans
L Silvia Munoz-Price
P304
P356
10.1086/432121
P407
P577
2005-08-01T00:00:00Z